Drug Manufacturers - Drug Take-Back Programs
Sponsor: Delegate Young, K.Committee: Health and Government OperationsSubject: Public HealthStatus: Hearing 3/14 at 1:00 p.m. (as of Sep 19, 2019)
What this bill does
Official synopsis
Requiring manufacturers of certain drugs to operate a certain drug take-back program or enter into a certain agreement with a drug take-back organization or the Maryland Department of Health; requiring, on or before a certain date, manufacturers of certain drugs and certain drug take-back organizations to submit a certain proposal to the Department; requiring manufacturers of certain drugs to pay certain costs and fees associated with the drug take-back program; etc.
AI analysis is off. Set ANTHROPIC_API_KEY to enable summaries, pros and cons, and questions.
Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.
Testimony (0)
MGA witness listNo witness list on file. It is scraped after hearings are scheduled; check the MGA link above.